title: Human bocavirus (HBoV) in children with respiratory tract infection by enzyme linked immunosorbent assay (ELISA) and qualitative polymerase chain reaction (PCR).
abstract: BACKGROUND
  Human bocavirus (HBoV) is a recently discovered parvovirus associated with mild to severe lower respiratory tract infections in children, the aim of the work was determination of human bocavirus in nasopharyngeal aspirate (NPA) of infants by qualitative PCR and determination of acute human bocavirus infection by estimation of immunoglobulin M (IgM) antibodies in serum by enzyme linked immunosorbent assay.
  
  
  RESULTS
  Twenty two (22%) out of the 100 NPA specimens of the patients with respiratory manifestations were positive for HBoV by qualitative PCR, while ELISA revealed positive HBoV IgM antibodies in 18 (18%) patients who were also positive by PCR. Non of the controls were positive by both techniques. The correlation study between ELISA and PCR revealed high significant association, (p < 0.001, X2 = 36 and agreement = 96%). Also PCR detected 4 (18.1%) NPA samples as HBoV positive cases among the patients that were not identified by ELISA. This could be due to high sensitivity and efficacy of PCR. ELISA being less sensitive than RT-PCR, sensitivity was (81.8% vs 100%), the efficacy was 97.7% in ELISA versus 99.7% for RT-PCR.
  
  
  CONCLUSIONS
  HBoV infections could be diagnosed in NPA of children by conventional PCR as a rapid and sensitive technique. While ELISA was a reliable serologic analysis for diagnosis of acute HBoV infection by estimation IgM antibodies in serum.
authors: Department of Clinical Pathology, Ain Shams University Hospitals, Cairo, Egypt. monazaki_810@hotmail.com
authors: Mona Z
authors: MZ
authors: Zaghloul
references: Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12891-6
references: 16118271
references: J Infect. 2007 Mar;54(3):e125-7
references: 16968654
references: BMC Infect Dis. 2010 Jul 20;10:215
references: 20646318
references: Viral Immunol. 2008 Dec;21(4):443-9
references: 19115933
references: Pediatr Infect Dis J. 2007 Feb;26(2):177-9
references: 17259883
references: J Infect Dis. 2006 Nov 1;194(9):1283-90
references: 17041855
references: Clin Microbiol Rev. 2008 Apr;21(2):291-304, table of contents
references: 18400798
references: J Virol. 2009 Aug;83(15):7739-48
references: 19474096
references: Curr Opin Infect Dis. 2005 Apr;18(2):141-6
references: 15735418
references: J Allergy Clin Immunol. 1990 May;85(5):828-33
references: 2332562
references: Intervirology. 2008;51(2):116-22
references: 18536522
references: J Clin Microbiol. 2007 Feb;45(2):610-3
references: 17122013
references: J Clin Microbiol. 2007 Jul;45(7):2116-22
references: 17475762
references: J Infect Dis. 2007 Oct 1;196(7):986-93
references: 17763318
references: J Clin Virol. 2006 Jan;35(1):99-102
references: 16257260
references: Clin Vaccine Immunol. 2009 May;16(5):597-604
references: 19244471
references: J Med Virol. 2006 Sep;78(9):1232-40
references: 16847968
references: Emerg Infect Dis. 2009 Sep;15(9):1423-30
references: 19788810
references: J Virol. 2005 Jan;79(2):884-95
references: 15613317
references: Clin Infect Dis. 2006 Aug 1;43(3):283-8
references: 16804840
references: Emerg Infect Dis. 2006 Sep;12(9):1457-8
references: 17073104
references: J Infect Dis. 2007 Oct 1;196(7):994-7
references: 17763319
references: J Clin Microbiol. 2007 Oct;45(10):3218-23
references: 17699639
references: BMC Infect Dis. 2006 Jul 11;6:109
references: 16834781
references: Clin Infect Dis. 2008 Feb 15;46(4):540-6
references: 18199037